Literature DB >> 1882000

Sensitization to systemic amphetamine produces an enhanced locomotor response to a subsequent intra-accumbens amphetamine challenge in rats.

P E Paulson1, T E Robinson.   

Abstract

Repeated amphetamine (AMPH) administration into the nucleus accumbens does not enhance (sensitize) the locomotor activity produced by a subsequent systemic AMPH challenge. We report here, however, that pretreatment with systemic injections of AMPH does produce a significant enhancement in the locomotor stimulant effects produced by intra-accumbens AMPH given 21 days after the last pretreatment injection of AMPH. These data support the hypothesis that neural adaptations in dopamine (DA) terminal fields are sufficient for the expression of AMPH sensitization, although an action on DA cell bodies may be required for the induction of AMPH sensitization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1882000      PMCID: PMC1859850          DOI: 10.1007/bf02244569

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  Enhanced responsiveness to intraventricular infusion of amphetamine following its repeated systemic administration.

Authors:  G V Rebec; D S Segal
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

2.  Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion.

Authors:  T E Robinson; D M Camp
Journal:  Pharmacol Biochem Behav       Date:  1987-04       Impact factor: 3.533

3.  Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine.

Authors:  J Stewart; P Vezina
Journal:  Brain Res       Date:  1989-08-28       Impact factor: 3.252

4.  Effects of systemic and intracranial amphetamine injections on behavior in the open field: a detailed analysis.

Authors:  G D Carr; N M White
Journal:  Pharmacol Biochem Behav       Date:  1987-05       Impact factor: 3.533

5.  Chronic D-amphetamine in nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity.

Authors:  G G Dougherty; E H Ellinwood
Journal:  Life Sci       Date:  1981-05-18       Impact factor: 5.037

6.  Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro.

Authors:  T E Robinson; J B Becker
Journal:  Eur J Pharmacol       Date:  1982-11-19       Impact factor: 4.432

Review 7.  Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.

Authors:  T E Robinson; J B Becker
Journal:  Brain Res       Date:  1986-06       Impact factor: 3.252

8.  Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects.

Authors:  P Vezina; J Stewart
Journal:  Brain Res       Date:  1990-05-14       Impact factor: 3.252

9.  Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens.

Authors:  M G Kolta; P Shreve; N J Uretsky
Journal:  Neuropharmacology       Date:  1989-01       Impact factor: 5.250

10.  Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine.

Authors:  P W Kalivas; B Weber
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

  10 in total
  12 in total

1.  Nucleus accumbens lesions modulate the effects of methylphenidate.

Authors:  Adam Podet; Min J Lee; Alan C Swann; Nachum Dafny
Journal:  Brain Res Bull       Date:  2010-05-12       Impact factor: 4.077

2.  Potential serotonin 5-HT(1A) and dopamine D(4) receptor modulation of the discriminative stimulus effects of amphetamine in rats.

Authors:  Danuta Marona-Lewicka; David E Nichols
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

3.  Spontaneous and drug-stimulated locomotor activity after the administration of pertussis toxin into the ventral tegmental area.

Authors:  S Narayanan; L Wallace; N Uretsky
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

4.  Alcohol-preferring (P) rats are more sensitive than Wistar rats to the reinforcing effects of cocaine self-administered directly into the nucleus accumbens shell.

Authors:  Simon N Katner; Scott M Oster; Zheng-Ming Ding; Gerald A Deehan; Jamie E Toalston; Sheketha R Hauser; William J McBride; Zachary A Rodd
Journal:  Pharmacol Biochem Behav       Date:  2011-06-25       Impact factor: 3.533

5.  Balanced NMDA receptor activity in dopamine D1 receptor (D1R)- and D2R-expressing medium spiny neurons is required for amphetamine sensitization.

Authors:  Lisa R Beutler; Matthew J Wanat; Albert Quintana; Elisenda Sanz; Nigel S Bamford; Larry S Zweifel; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

6.  The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.

Authors:  Maurice Y F Shen; Melissa L Perreault; Theresa Fan; Susan R George
Journal:  Pharmacol Biochem Behav       Date:  2014-11-13       Impact factor: 3.533

7.  Chemogenetic modulation reveals distinct roles of the subthalamic nucleus and its afferents in the regulation of locomotor sensitization to amphetamine in rats.

Authors:  K G Nakata; E Yin; E Sutlief; Susan M Ferguson
Journal:  Psychopharmacology (Berl)       Date:  2021-09-22       Impact factor: 4.530

Review 8.  Behavioral characteristics and neurobiological substrates shared by Pavlovian sign-tracking and drug abuse.

Authors:  Arthur Tomie; Kathryn L Grimes; Larissa A Pohorecky
Journal:  Brain Res Rev       Date:  2007-12-28

9.  Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol.

Authors:  Emmanuel Valjent; Jesus Bertran-Gonzalez; Benjamin Aubier; Paul Greengard; Denis Hervé; Jean-Antoine Girault
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 10.  Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior.

Authors:  Kathryn D Fischer; Lori A Knackstedt; Paul A Rosenberg
Journal:  Neurochem Int       Date:  2020-11-05       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.